Nefense Launches Hypochlorous Acid Nasal Spray Line for All Ages
Nefense introduces Hyponasal, Hyponasal Junior, and Hypobaby, a drug-free HOCl nasal spray family targeting airway hygiene for adults, children, and infants, responding to growing consumer interest in respiratory wellness.

Nefense®, a company specializing in advanced clinical hygiene and airway health solutions, has officially launched its hypochlorous acid (HOCl) nasal spray line, marking a significant expansion into age-specific airway care. The new product family includes Hyponasal, Hyponasal Junior, and Hypobaby, offering a drug-free approach to nasal hygiene for adults, children, and infants. This launch underscores the increasing consumer demand for respiratory wellness products that support healthy breathing without reliance on medications or steroids.
The flagship product, Hyponasal HOCl Nose Spray, is designed as a daily biocleanse for nasal passages, helping to flush environmental irritants while supporting the body’s natural respiratory defenses. According to Dr. Richard D. Downs, D.D.S., "Proper airway management begins with maintaining a clean and healthy nasal cavity. With Hyponasal, we are providing a superior biocleanse solution that addresses daily irritation at its source." The formulation leverages Ionoxx Hypochlorous Acid, a molecule naturally produced by the immune system, which has gained attention in healthcare for its anti-microbial and anti-inflammatory properties.
For individuals seeking natural alternatives for allergy relief or everyday respiratory hygiene, HOCl offers a non-habit-forming option. Dr. Joseph Zelk, a sleep specialist collaborating with Nefense, noted, "The anti-inflammatory and antimicrobial properties of HOCl make it a remarkable tool for naturally clearing the airway, mitigating allergies, and supporting healthier breathing."
Recognizing the need for pediatric solutions, Nefense simultaneously introduced Hyponasal Jr. and Hypobaby, tailored for sensitive nasal passages of children and infants. Dr. Shane Smith emphasized the challenge parents face: "Parents constantly struggle to find safe, drug-free solutions for their children’s congestion. Hypobaby and Hyponasal Jr. offer unparalleled peace of mind."
The launch aligns with growing consumer interest in airway wellness, nasal hygiene, and sleep-supportive breathing practices. Nefense’s portfolio now includes XyloClean, a xylitol-based nasal spray, and the company works with doctors and ENT specialists to develop science-driven products. For more information, visit Nefense.com.
This product expansion represents a strategic move to address respiratory health across all life stages, potentially influencing how consumers and healthcare professionals approach daily nasal care. By providing age-specific, drug-free options, Nefense aims to set a new standard in airway hygiene and respiratory wellness.